Could a common heart pill curb alcohol cravings?

NCT ID NCT05807139

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 5 times

Summary

This early-phase study tests whether spironolactone, a drug currently used for high blood pressure and heart failure, can be safely used in people with alcohol use disorder. Twenty participants will each stay at a clinic four times, taking either the drug or a placebo for five days, then drinking alcohol in a controlled setting. Researchers will measure how the body processes the drug and alcohol, and check for side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Spironolactone
What this could lead to
If this early study shows that spironolactone is safe and reduces alcohol craving or consumption, it could point toward a new treatment option for alcohol use disorder.
What could go wrong
This is a very small Phase 1b safety and dosing study with only 20 participants. It is not designed to prove effectiveness, and the drug may not reduce drinking in real-world settings. Side effects like high potassium or kidney issues are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institute on Drug Abuse

    RECRUITING

    Baltimore, Maryland, 21224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.